(Q34979800)

5 August 2017

1 reference

title

The use of PCA3 in the diagnosis of prostate cancer (English)

1 reference

5 August 2017

1 reference

Daphne Hessels

1

1 reference

5 August 2017

Jack A Schalken

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

5 August 2017

published in

Nature Reviews Urology

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

255-261

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2009.40

5 August 2017

exact match

0 references

cites work

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Estimates of the cancer incidence and mortality in Europe in 2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Applicability of biomarkers in the early diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Molecular PCA3 diagnostics on prostatic fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

PCA3: a molecular urine assay for predicting prostate biopsy outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.40

The expression of a variant prostate-specific antigen in human prostate.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19424173

12 December 2020

inferred from PubMed ID database lookup

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19424173

12 December 2020

inferred from PubMed ID database lookup

DD3(PCA3), a very sensitive and specific marker to detect prostate tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19424173

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRUROL.2009.40

1 reference

Dimensions Publication ID

5 August 2017

1007925132

0 references

Fatcat ID

release_bhkkec75lrelrofqbq273hf54a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bhkkec75lrelrofqbq273hf54a

24 November 2022

mapped directly with Wikidata item

1 reference